A Study Of Prostate Cancer Survivorship (CaPS) Model For Black Prostate Cancer Survivors

Overview

About this study

The purpose of this study is to employ grounded theory to develop an exploratory model of CaP-SC for ethnically diverse Black CaP survivors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Identify as Black or as both Black and Afro-Latino

  • Prostate Cancer Self-Care survivor

  • Age 40- 75

  • Completed their CaP Prostate Cancer Self-Care treatment, including purposive sampling of NH and Hispanic BM

Exclusion Criteria:

  • Under 40 years old

  • Have not completed prostate cancer treatment

  • Men on watchful waiting

  • Unable to participate in video journaling due to technology limitations or discomfort with using digital devices such as an iPad

  • Do not identify as Black or as both Black and Afro-Latino

  • Are not fluent in English or Spanish, which are the languages supported by the AI-generated avatars and study materials.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/01/2026. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ewan Cobran, Ph.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Jacksonville, Fla.

Mayo Clinic principal investigator

Ewan Cobran, Ph.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions